Severe myopericarditis following induction therapy with idarubicin and transretinoic acid in a patient with acute promyelocytic leukemia

Med Clin (Barc). 2018 Jun 22;150(12):492-493. doi: 10.1016/j.medcli.2017.10.030. Epub 2017 Nov 28.
[Article in English, Spanish]
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Anti-Inflammatory Agents / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Arsenic Trioxide / administration & dosage
  • Cardiovascular Agents / therapeutic use
  • Chest Pain / etiology
  • Drug Substitution
  • Echocardiography
  • Electrocardiography
  • Humans
  • Idarubicin / administration & dosage
  • Idarubicin / adverse effects*
  • Leukemia, Promyelocytic, Acute / drug therapy*
  • Male
  • Myocarditis / chemically induced*
  • Myocarditis / diagnostic imaging
  • Myocarditis / drug therapy
  • Pericarditis / chemically induced*
  • Pericarditis / diagnostic imaging
  • Pericarditis / drug therapy
  • Remission Induction
  • Tretinoin / administration & dosage
  • Tretinoin / adverse effects*

Substances

  • Anti-Inflammatory Agents
  • Cardiovascular Agents
  • Tretinoin
  • Arsenic Trioxide
  • Idarubicin